Acknowledged risks in transfusion and impact of taken measures on those risks;Risques connus et impact de mesures prises sur ces risques en transfusion sanguine

Transfusion Clinique et Biologique

Volumn 18, Issue 4, 2011, Pages 463-467

  Garraud, Olivier ^a,b,c,d  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Pathogen inactivation; Quality; Risk; Risk assessment; Risk management; Safety; Transfusion; Vigilance

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; ECONOMIC ASPECT; ENGINEERING; ENVIRONMENTAL IMPACT; ETHICS; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATHOGEN REDUCTION PROCEDURE; POLICY; PROCESS DESIGN; PROCESS OPTIMIZATION; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; STANDARD; TREATMENT PLANNING;

BLOOD TRANSFUSION; HUMANS; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 80051565690     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2011.05.001     Document Type: Article

References (19)

1. http://www.courdecassation.fr/publications_cour_26/rapport_annuel_36/rapport_2007_2640/etude_sante_2646/dommages_survenus_2650/etablissement_responsabilite_2651/caractere_multifactoriel_11383.html.
2. Allain J.P., Stramer S.L., Carneiro-Proietti A.B., Martins M.L., Lopes da Silva S.N., Ribeiro M., et al. Transfusion-transmitted infectious diseases. Biologicals 2009, 37:71-77.
3. Trimble S.R., Parker C.S., Grant A.M., Soucie J.M., Reyes N. Assessing emerging infectious threats to blood safety for the blood disorders community. Am J Prev Med 2010, 38:68-74.
4. Zanetti A.R., Zappa A. Emerging and re-emerging infections at the turn of the millennium. Haemophilia 2010, 16(S1):7-12.
5. Menéndez-Arias L. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome. Rev Med Virol 2011, 21:3-17.
6. Tang S., Zhao J., Viswanath R., Nyambi P.N., Redd A.D., Dastyar A., et al. Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa. Transfusion 2011, 51:463-468.
7. Brown P. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 2007, 13(S5):33-40.
8. Calistri P., Giovannini A., Hubalek Z., Ionescu A., Monaco F., Savini G., et al. Epidemiology of west nile in europe and in the mediterranean basin. Open Virol J 2010, 4:29-37.
9. Martinot M., Mohseni Zadeh M., Hansmann Y., Grawey I., Christmann D., Aguillon S., et al. Babesiosis in immunocompetent patients, europe. Emerg Infect Dis 2011, 17:114-116.
10. Epstein J.S. Alternative strategies in assuring blood safety: an overview. Biologicals 2010, 38:31-35.
11. Dodd R., Kurt Roth W., Ashford P., Dax E.M., Vyas G. Transfusion medicine and safety. Biologicals 2009, 37:62-70.
12. Sandler S.G. The status of pathogen-reduced plasma. Transfus Apher Sci 2010, 43:393-399.
13. Solheim B.G. Pathogen reduction of blood components. Transfus Apher Sci 2008, 39:75-78.
14. Klein H.G., Glynn S.A., Ness P.M., Blajchman M.A. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop. Transfusion 2009, 49:1262-1268. NHLBI Working Group on Research Opportunities for the Pathogen Reduction/Inactivation of Blood Components.
15. Dwyre D.M., Fernando L.P., Holland P.V. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 2011, 100:92-98.
16. Rasonglès P., Angelini-Tibert M.F., Simon P., Currie C., Isola H., Kientz D., et al. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Île de La Réunion. Transfusion 2009, 49:1083-1091.
17. Roest H.I., Tilburg J.J., Van der Hoek W., Vellema P., Van Zijderveld F.G., Klaassen C.H., et al. The Q fever epidemic in the Netherlands: history, onset, response and reflection. Epidemiol Infect 2011, 139:1-12.
18. Bay J.O., Tournilhac O., Ducher E., Romaszko J.P., Ergani A., Bouvet A., et al. A near fatal septic transfusion reaction due to Streptococcus dysgalactiae subspecies equisimilis calls for novel safety measures. Vox Sang 2009, 96:271.
19. Dong J., Olano J.P., McBride J.W., Walker D.H. Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn 2008, 10:185-197.